Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:21:10.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the record history and Revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:10:52.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:27:10.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; deletions remove a government-funding notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:14:14.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a revision note (v3.4.1); removed the previous revision note (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T10:30:53.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    UI updates in the history page include a Show glossary option and color-coded change highlights (green for additions, red for deletions) with a Revision: v3.4.0 banner. Additionally, the No FEAR Act data entry and the older Revision: v3.3.4 entry were removed.
    Difference
    0.6%
    Check dated 2026-01-28T06:15:00.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.